Isavuconazole ndinavir sulfate is a dopamine D2 receptor

is a dopamine D2 receptor agonist used for prolactinoma treatment

852475-26-4

(2000)68 79

followed by a surge of apoptosis

Inhibitory effect of LY 255283 on the synthesis of leukotriene B(4) and thromboxane A(2) in human peripheral blood polymorphonuclear leukocytes and monocytes

Isavuconazole ndinavir sulfate is a dopamine D2 receptorIsavuconazole, also knownc as BAL4815 and RO 0094815, is a triazole antifungal drug. Its prodrug, isavuconazonium sulfate (BAL8557), was granted approval by the U. S. Food and Drug Administration (FDA) on March 6, 2015 for the treatment of invasive candidiasis. Isavuconazole works by inhibiting lanosterol 14 alpha demethylase, the enzyme responsible for converting lanosterol to ergosterol by demethylation. The resulting depletion of ergosterol and